Prorenone
Prorenone (developmental code name SC-23133) is a steroidal antimineralocorticoid of the spirolactone group related to spironolactone that was never marketed.[1] It is the lactonic form of prorenoic acid (prorenoate), and prorenoate potassium (SC-23992), the potassium salt of prorenoic acid, also exists.[1] Prorenoate potassium is about 8 times more potent than spironolactone as an antimineralocorticoid in animals, and it may act as a prodrug to prorenone.[1] In addition to the mineralocorticoid receptor, prorenone also binds to the glucocorticoid, androgen, and progesterone receptors.[2][3] The antiandrogenic potency of prorenone in vivo in animals is close to that of spironolactone.[3] Similarly to spironolactone, prorenone is also a potent inhibitor of aldosterone biosynthesis.[4]
Clinical data | |
---|---|
Other names | SC-23133; 3-(17β-Hydroxy-6β,7β-methylene-3-oxo-4-androsten-17α-yl)propionic acid γ-lactone |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H30O3 |
Molar mass | 354.490 g·mol−1 |
3D model (JSmol) | |
| |
|
Chemistry
Synthesis
Prorenone can be synthesized via a Johnson–Corey–Chaykovsky reaction by reaction of canrenone with trimethylsulfonium iodide and sodium hydride.[5]
References
- Claire, M.; Rafestin-Oblin, M. E.; Michaud, A.; Roth-Meyer, C.; Corvol, P. (1979). "Mechanism of Action of a New Antialdosterone Compound, Prorenone*". Endocrinology. 104 (4): 1194–1200. doi:10.1210/endo-104-4-1194. ISSN 0013-7227. PMID 436757.
- Gyorgy Szasz; Zsuzsanna Budvari-Barany (19 December 1990). Pharmaceutical Chemistry of Antihypertensive Agents. CRC Press. pp. 87–. ISBN 978-0-8493-4724-5.
- Kamata S, Matsui T, Haga N, Nakamura M, Odaguchi K, Itoh T, Shimizu T, Suzuki T, Ishibashi M, Yamada F (September 1987). "Aldosterone antagonists. 2. Synthesis and biological activities of 11,12-dehydropregnane derivatives". J. Med. Chem. 30 (9): 1647–58. doi:10.1021/jm00392a022. PMID 3040999.
- Netchitailo, Pierre; Delarue, Catherine; Perroteau, Isabelle; Leboulenger, Francois; Capron, Michel-Hubert; Vaudry, Hubert (1985). "Relative inhibitory potency of five mineralocorticoid antagonists on aldosterone biosynthesis in vitro". Biochemical Pharmacology. 34 (2): 189–194. doi:10.1016/0006-2952(85)90123-6. ISSN 0006-2952. PMID 2981534.
- Chinn, L.; 1974, U.S. Patent 3,845,041